Structure Therapeutics Inc ADR [NASDAQ: GPCR] slipped around -0.37 points on Wednesday, while shares priced at $19.71 at the close of the session, down -1.84%.
Structure Therapeutics Inc ADR stock is now -48.56% down from its year-to-date (YTD) trading value. GPCR Stock saw the intraday high of $21.225 and lowest of $19.225 per share. The company’s 52-week high price is 45.37, which means current price is +49.09% above from all time high which was touched on 01/31/25.
Compared to the average trading volume of 792.49K shares, GPCR reached a trading volume of 6056530 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Structure Therapeutics Inc ADR [GPCR]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GPCR shares is $75.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GPCR stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Structure Therapeutics Inc ADR shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 02, 2025. While these analysts kept the previous recommendation, William Blair raised their target price to Outperform. The new note on the price target was released on February 28, 2025, representing the official price target for Structure Therapeutics Inc ADR stock. Previously, the target price had yet another raise to $50, while Stifel analysts kept a Buy rating on GPCR stock.
The Price to Book ratio for the last quarter was 1.47, with the Price to Cash per share for the same quarter was set at 13.66.
How has GPCR stock performed recently?
Structure Therapeutics Inc ADR [GPCR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.73. With this latest performance, GPCR shares gained by 17.46% in over the last four-week period, additionally sinking by -12.36% over the last 6 months – not to mention a drop of -27.32% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GPCR stock in for the last two-week period is set at 56.11, with the RSI for the last a single of trading hit 1.11, and the three-weeks RSI is set at 1.10 for Structure Therapeutics Inc ADR [GPCR]. The present Moving Average for the last 50 days of trading for this stock 18.95, while it was recorded at 19.45 for the last single week of trading, and 23.63 for the last 200 days.
Structure Therapeutics Inc ADR (GPCR) Capital Structure & Debt Analysis
According to recent financial data for Structure Therapeutics Inc ADR. ( GPCR), the Return on Equity (ROE) stands at -21.19%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -20.34%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Structure Therapeutics Inc ADR’s Return on Invested Capital (ROIC) is -23.08%, showcasing its effectiveness in deploying capital for earnings.
Structure Therapeutics Inc ADR (GPCR) Efficiency & Liquidity Metrics
Based on Structure Therapeutics Inc ADR’s (GPCR) latest financial statements, the Debt-to-Equity Ratio is 0.01%, indicating its reliance on debt financing relative to shareholder equity.
Structure Therapeutics Inc ADR (GPCR) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Structure Therapeutics Inc ADR. (GPCR) effectively leverages its workforce, generating an average of -$1100490.8 per employee. The company’s liquidity position is robust, with a Current Ratio of 20.48% and a Quick Ratio of 20.48%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Structure Therapeutics Inc ADR [GPCR]
With the latest financial reports released by the company, Structure Therapeutics Inc ADR posted -0.2/share EPS, while the average EPS was predicted by analysts to be reported at -0.19/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GPCR.
Insider trade positions for Structure Therapeutics Inc ADR [GPCR]
There are presently around $98.17%, or 101.24%% of GPCR stock, in the hands of institutional investors. The top three institutional holders of GPCR stocks are: WELLINGTON MANAGEMENT GROUP LLP with ownership of 7.55 million shares, which is approximately 1.7124%. FMR LLC, holding 5.74 million shares of the stock with an approximate value of $$225.6 million in GPCR stocks shares; and FMR LLC, currently with $$131.65 million in GPCR stock with ownership which is approximately 0.761%.
